196 related articles for article (PubMed ID: 15194222)
1. Both BRAF and KRAS mutations are rare in colorectal carcinomas from patients with hereditary nonpolyposis colorectal cancer.
Miyaki M; Iijima T; Yamaguchi T; Kadofuku T; Funata N; Mori T
Cancer Lett; 2004 Jul; 211(1):105-9. PubMed ID: 15194222
[TBL] [Abstract][Full Text] [Related]
2. Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasia.
Yuen ST; Davies H; Chan TL; Ho JW; Bignell GR; Cox C; Stephens P; Edkins S; Tsui WW; Chan AS; Futreal PA; Stratton MR; Wooster R; Leung SY
Cancer Res; 2002 Nov; 62(22):6451-5. PubMed ID: 12438234
[TBL] [Abstract][Full Text] [Related]
3. BRAF mutation is frequently present in sporadic colorectal cancer with methylated hMLH1, but not in hereditary nonpolyposis colorectal cancer.
Deng G; Bell I; Crawley S; Gum J; Terdiman JP; Allen BA; Truta B; Sleisenger MH; Kim YS
Clin Cancer Res; 2004 Jan; 10(1 Pt 1):191-5. PubMed ID: 14734469
[TBL] [Abstract][Full Text] [Related]
4. Distinct patterns of KRAS mutations in colorectal carcinomas according to germline mismatch repair defects and hMLH1 methylation status.
Oliveira C; Westra JL; Arango D; Ollikainen M; Domingo E; Ferreira A; Velho S; Niessen R; Lagerstedt K; Alhopuro P; Laiho P; Veiga I; Teixeira MR; Ligtenberg M; Kleibeuker JH; Sijmons RH; Plukker JT; Imai K; Lage P; Hamelin R; Albuquerque C; Schwartz S; Lindblom A; Peltomaki P; Yamamoto H; Aaltonen LA; Seruca R; Hofstra RM
Hum Mol Genet; 2004 Oct; 13(19):2303-11. PubMed ID: 15294875
[TBL] [Abstract][Full Text] [Related]
5. BRAF-V600E is not involved in the colorectal tumorigenesis of HNPCC in patients with functional MLH1 and MSH2 genes.
Domingo E; Niessen RC; Oliveira C; Alhopuro P; Moutinho C; Espín E; Armengol M; Sijmons RH; Kleibeuker JH; Seruca R; Aaltonen LA; Imai K; Yamamoto H; Schwartz S; Hofstra RM
Oncogene; 2005 Jun; 24(24):3995-8. PubMed ID: 15782118
[TBL] [Abstract][Full Text] [Related]
6. Cancer risk and overall survival in mismatch repair proficient hereditary non-polyposis colorectal cancer, Lynch syndrome and sporadic colorectal cancer.
Garre P; Martín L; Bando I; Tosar A; Llovet P; Sanz J; Romero A; de la Hoya M; Díaz-Rubio E; Caldés T
Fam Cancer; 2014 Mar; 13(1):109-19. PubMed ID: 24061861
[TBL] [Abstract][Full Text] [Related]
7. Aberrant DNA methylation in hereditary nonpolyposis colorectal cancer without mismatch repair deficiency.
Goel A; Xicola RM; Nguyen TP; Doyle BJ; Sohn VR; Bandipalliam P; Rozek LS; Reyes J; Cordero C; Balaguer F; Castells A; Jover R; Andreu M; Syngal S; Boland CR; Llor X
Gastroenterology; 2010 May; 138(5):1854-62. PubMed ID: 20102720
[TBL] [Abstract][Full Text] [Related]
8. Mutational analysis of OGG1, MYH, MTH1 in FAP, HNPCC and sporadic colorectal cancer patients: R154H OGG1 polymorphism is associated with sporadic colorectal cancer patients.
Kim IJ; Ku JL; Kang HC; Park JH; Yoon KA; Shin Y; Park HW; Jang SG; Lim SK; Han SY; Shin YK; Lee MR; Jeong SY; Shin HR; Lee JS; Kim WH; Park JG
Hum Genet; 2004 Nov; 115(6):498-503. PubMed ID: 15449173
[TBL] [Abstract][Full Text] [Related]
9. Difference in the role of loss of heterozygosity at 10p15 (KLF6 locus) in colorectal carcinogenesis between sporadic and familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer patients.
Miyaki M; Yamaguchi T; Iijima T; Funata N; Mori T
Oncology; 2006; 71(1-2):131-5. PubMed ID: 17347589
[TBL] [Abstract][Full Text] [Related]
10. RAS/RAF mutation and defective DNA mismatch repair in endometrial cancers.
Mutch DG; Powell MA; Mallon MA; Goodfellow PJ
Am J Obstet Gynecol; 2004 Apr; 190(4):935-42. PubMed ID: 15118616
[TBL] [Abstract][Full Text] [Related]
11. Colorectal cancer with and without microsatellite instability involves different genes.
Salahshor S; Kressner U; Pâhlman L; Glimelius B; Lindmark G; Lindblom A
Genes Chromosomes Cancer; 1999 Nov; 26(3):247-52. PubMed ID: 10502323
[TBL] [Abstract][Full Text] [Related]
12. Concomitant RASSF1A hypermethylation and KRAS/BRAF mutations occur preferentially in MSI sporadic colorectal cancer.
Oliveira C; Velho S; Domingo E; Preto A; Hofstra RM; Hamelin R; Yamamoto H; Seruca R; Schwartz S
Oncogene; 2005 Nov; 24(51):7630-4. PubMed ID: 16007118
[TBL] [Abstract][Full Text] [Related]
13. Promoter hypermethylation frequency and BRAF mutations distinguish hereditary non-polyposis colon cancer from sporadic MSI-H colon cancer.
McGivern A; Wynter CV; Whitehall VL; Kambara T; Spring KJ; Walsh MD; Barker MA; Arnold S; Simms LA; Leggett BA; Young J; Jass JR
Fam Cancer; 2004; 3(2):101-7. PubMed ID: 15340260
[TBL] [Abstract][Full Text] [Related]
14. Activated BRAF targets proximal colon tumors with mismatch repair deficiency and MLH1 inactivation.
Domingo E; Espín E; Armengol M; Oliveira C; Pinto M; Duval A; Brennetot C; Seruca R; Hamelin R; Yamamoto H; Schwartz S
Genes Chromosomes Cancer; 2004 Feb; 39(2):138-42. PubMed ID: 14695993
[TBL] [Abstract][Full Text] [Related]
15. Distinction of hereditary nonpolyposis colorectal cancer and sporadic microsatellite-unstable colorectal cancer through quantification of MLH1 methylation by real-time PCR.
Bettstetter M; Dechant S; Ruemmele P; Grabowski M; Keller G; Holinski-Feder E; Hartmann A; Hofstaedter F; Dietmaier W
Clin Cancer Res; 2007 Jun; 13(11):3221-8. PubMed ID: 17545526
[TBL] [Abstract][Full Text] [Related]
16. In ovarian neoplasms, BRAF, but not KRAS, mutations are restricted to low-grade serous tumours.
Sieben NL; Macropoulos P; Roemen GM; Kolkman-Uljee SM; Jan Fleuren G; Houmadi R; Diss T; Warren B; Al Adnani M; De Goeij AP; Krausz T; Flanagan AM
J Pathol; 2004 Mar; 202(3):336-40. PubMed ID: 14991899
[TBL] [Abstract][Full Text] [Related]
17. Familial adenomatous polyposis (FAP) and hereditary nonpolyposis colorectal cancer (HNPCC): a review of clinical, genetic and therapeutic aspects.
Soravia C; Bapat B; Cohen Z
Schweiz Med Wochenschr; 1997 Apr; 127(16):682-90. PubMed ID: 9140167
[TBL] [Abstract][Full Text] [Related]
18. Exon 3 beta-catenin mutations are specifically associated with colorectal carcinomas in hereditary non-polyposis colorectal cancer syndrome.
Johnson V; Volikos E; Halford SE; Eftekhar Sadat ET; Popat S; Talbot I; Truninger K; Martin J; Jass J; Houlston R; Atkin W; Tomlinson IP; Silver AR
Gut; 2005 Feb; 54(2):264-7. PubMed ID: 15647192
[TBL] [Abstract][Full Text] [Related]
19. Mutations of the PIK3CA gene in hereditary colorectal cancers.
Miyaki M; Iijima T; Yamaguchi T; Takahashi K; Matsumoto H; Yasutome M; Funata N; Mori T
Int J Cancer; 2007 Oct; 121(7):1627-30. PubMed ID: 17546593
[TBL] [Abstract][Full Text] [Related]
20. BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing.
Domingo E; Laiho P; Ollikainen M; Pinto M; Wang L; French AJ; Westra J; Frebourg T; Espín E; Armengol M; Hamelin R; Yamamoto H; Hofstra RM; Seruca R; Lindblom A; Peltomäki P; Thibodeau SN; Aaltonen LA; Schwartz S
J Med Genet; 2004 Sep; 41(9):664-8. PubMed ID: 15342696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
